HealthQuill Travel restrictions
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More